These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 9140672)
1. Attenuation of stunning by the calcium antagonist nisoldipine in patients with myocardial infarction and early percutaneous transluminal coronary angioplasty. Heusch G Cardiovasc Drugs Ther; 1997 Mar; 11(1):19-20. PubMed ID: 9140672 [No Abstract] [Full Text] [Related]
2. Recovery of left ventricular function following early reperfusion in acute myocardial infarction: a potential role for the calcium antagonist nisoldipine. Sheiban I; Tonni S; Chizzoni A; Marini A; Trevi G Cardiovasc Drugs Ther; 1997 Mar; 11(1):5-16. PubMed ID: 9140670 [TBL] [Abstract][Full Text] [Related]
3. Clinical evidence that nisoldipine attenuates stunning in patients post infarction. Kloner RA; Przyklenk K Cardiovasc Drugs Ther; 1997 Mar; 11(1):17-8. PubMed ID: 9140671 [No Abstract] [Full Text] [Related]
4. Myocardial stunning following coronary angioplasty: protective effects of calcium-channel blockers. Sheiban I; Tonni S; Benussi P; Marini A; Montresor G; Trevi GP J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S18-24. PubMed ID: 1282609 [TBL] [Abstract][Full Text] [Related]
5. Postischemic mechanical and vascular dysfunction (myocardial "stunning" and microvascular "stunning") and the effects of calcium-channel blockers on ischemia/reperfusion injury. Bolli R; Triana F; Jeroudi MO Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III16-25. PubMed ID: 2691139 [TBL] [Abstract][Full Text] [Related]
6. Left ventricular dysfunction following transient ischaemia induced by transluminal coronary angioplasty. Beneficial effects of calcium antagonists against post-ischaemic myocardial stunning. Sheiban I; Tonni S; Benussi P; Marini A; Trevi GP Eur Heart J; 1993 Jul; 14 Suppl A():14-21. PubMed ID: 8370356 [TBL] [Abstract][Full Text] [Related]
7. Beneficial effect of nisoldipine in repeated coronary reperfusion. Hammerman H; Moscovitz M; Hir J Coron Artery Dis; 1997 Feb; 8(2):97-100. PubMed ID: 9211049 [TBL] [Abstract][Full Text] [Related]
8. [Reperfusion in myocardial infarction: a two-edged sword]. Emanuelsson H; Währborg P Lakartidningen; 1996 Mar; 93(12):1112-5. PubMed ID: 8649073 [No Abstract] [Full Text] [Related]
9. Usefulness of Nisoldipine for prevention of restenosis after percutaneous transluminal coronary angioplasty (results of the NICOLE study). NIsoldipine in COronary artery disease in LEuven. Dens JA; Desmet WJ; Coussement P; De Scheerder IK; Kostopoulos K; Kerdsinchai P; Supanantaroek C; Piessens JH Am J Cardiol; 2001 Jan; 87(1):28-33. PubMed ID: 11137829 [TBL] [Abstract][Full Text] [Related]
10. Dihydropyridine calcium antagonists: beneficial or adverse effects in the setting of myocardial ischaemia/reperfusion? Ehring T; Heusch G Cardiology; 1997; 88 Suppl 1():3-14; discussion 15-6. PubMed ID: 9118166 [TBL] [Abstract][Full Text] [Related]
11. Nisoldipine attenuates myocardial stunning induced by multiple coronary occlusions in conscious pigs and this effect is independent of changes in hemodynamics or coronary blood flow. Park SW; Tang XL; Qiu Y; Sun JZ; Bolli R J Mol Cell Cardiol; 1996 Apr; 28(4):655-66. PubMed ID: 8732494 [TBL] [Abstract][Full Text] [Related]
12. DEFIANT-II: a study of nisoldipine CC after myocardial infarction. Doppler flow and Echocardiography in Functional cardiac Insufficiency: Assessment of Nisoldipine Therapy investigators. Hall R Cardiovasc Drugs Ther; 1997 Jan; 10 Suppl 3():881. PubMed ID: 9126677 [No Abstract] [Full Text] [Related]
13. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention. Ishii H; Ichimiya S; Kanashiro M; Aoyama T; Ogawa Y; Murakami R; Amano T; Naruse K; Matsubara T; Murohara T Clin Ther; 2006 Nov; 28(11):1812-9. PubMed ID: 17213001 [TBL] [Abstract][Full Text] [Related]
14. Potential of microvascular reperfusion with adjunctive pharmacological intervention: its impact on myocardial perfusion and functional outcomes in patients with acute myocardial infarction. Taniyama Y; Ito H; Morishita R; Ogihara T Drugs; 2001; 61(4):437-41. PubMed ID: 11324678 [TBL] [Abstract][Full Text] [Related]
15. Association between right bundle branch block and impaired myocardial tissue-level reperfusion in patients with acute myocardial infarction. Suzuki M; Sakaue T; Tanaka M; Hirose E; Saeki H; Matsunaka T; Hiramatsu S; Kazatani Y J Am Coll Cardiol; 2006 May; 47(10):2122-4. PubMed ID: 16697336 [No Abstract] [Full Text] [Related]
16. [Study of no-reflow phenomenon after reperfusion for acute myocardial infarction]. Yang YJ; Zhao JL Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(31):2169-70. PubMed ID: 16321176 [No Abstract] [Full Text] [Related]
17. Reperfusion arrhythmias and ST-segment resolution. Zahger D; Ilia R Am J Cardiol; 2004 Mar; 93(5):671. PubMed ID: 14996611 [No Abstract] [Full Text] [Related]
18. Calcium antagonists in myocardial ischemia/reperfusion--update 2012. Kleinbongard P; Baars T; Heusch G Wien Med Wochenschr; 2012 Jul; 162(13-14):302-10. PubMed ID: 22695811 [TBL] [Abstract][Full Text] [Related]
19. Ischemic time: the new gold standard for ST-segment elevation myocardial infarction care. Smalling RW J Am Coll Cardiol; 2009 Dec; 54(23):2154-6. PubMed ID: 19942087 [No Abstract] [Full Text] [Related]
20. Microvascular dysfunction following primary percutaneous coronary intervention in the setting of ST-elevation myocardial infarction. Ramaraj R; Movahed MR J Invasive Cardiol; 2008 Nov; 20(11):603-14. PubMed ID: 18987402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]